Geode Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.5M | Buy |
1,995,271
+45,225
| +2% | +$783K | ﹤0.01% | 1632 |
|
|
2025
Q1 | $42.7M | Buy |
1,950,046
+111,094
| +6% | +$2.43M | ﹤0.01% | 1468 |
|
|
2024
Q4 | $58.7M | Buy |
1,838,952
+28,426
| +2% | +$907K | ﹤0.01% | 1331 |
|
|
2024
Q3 | $52.2M | Buy |
1,810,526
+22,609
| +1% | +$652K | ﹤0.01% | 1399 |
|
|
2024
Q2 | $68.6M | Buy |
1,787,917
+98,027
| +6% | +$3.76M | 0.01% | 1152 |
|
|
2024
Q1 | $99.4M | Buy |
1,689,890
+59,248
| +4% | +$3.48M | 0.01% | 923 |
|
|
2023
Q4 | $97.6M | Buy |
1,630,642
+75,816
| +5% | +$4.54M | 0.01% | 885 |
|
|
2023
Q3 | $59.2M | Buy |
1,554,826
+56,437
| +4% | +$2.15M | 0.01% | 1121 |
|
|
2023
Q2 | $137M | Sell |
1,498,389
-339,890
| -18% | -$31M | 0.02% | 636 |
|
|
2023
Q1 | $121M | Buy |
1,838,279
+88,278
| +5% | +$5.82M | 0.02% | 658 |
|
|
2022
Q4 | $90.5M | Buy |
1,750,001
+58,799
| +3% | +$3.04M | 0.01% | 763 |
|
|
2022
Q3 | $116M | Buy |
1,691,202
+81,040
| +5% | +$5.54M | 0.02% | 629 |
|
|
2022
Q2 | $72.8M | Buy |
1,610,162
+116,642
| +8% | +$5.27M | 0.01% | 868 |
|
|
2022
Q1 | $75.9M | Buy |
1,493,520
+140,691
| +10% | +$7.15M | 0.01% | 944 |
|
|
2021
Q4 | $64M | Buy |
1,352,829
+164,437
| +14% | +$7.77M | 0.01% | 1118 |
|
|
2021
Q3 | $39.2M | Buy |
1,188,392
+70,257
| +6% | +$2.32M | 0.01% | 1471 |
|
|
2021
Q2 | $70.7M | Buy |
1,118,135
+71,222
| +7% | +$4.5M | 0.01% | 1020 |
|
|
2021
Q1 | $44.9M | Buy |
1,046,913
+110,380
| +12% | +$4.74M | 0.01% | 1317 |
|
|
2020
Q4 | $53.6M | Buy |
936,533
+58,719
| +7% | +$3.36M | 0.01% | 1046 |
|
|
2020
Q3 | $26.5M | Buy |
877,814
+11,916
| +1% | +$359K | 0.01% | 1318 |
|
|
2020
Q2 | $28.3M | Buy |
865,898
+37,849
| +5% | +$1.24M | 0.01% | 1247 |
|
|
2020
Q1 | $22.2M | Buy |
828,049
+170,112
| +26% | +$4.56M | 0.01% | 1223 |
|
|
2019
Q4 | $20.1M | Buy |
657,937
+31,187
| +5% | +$955K | ﹤0.01% | 1553 |
|
|
2019
Q3 | $15.1M | Buy |
626,750
+48,753
| +8% | +$1.17M | ﹤0.01% | 1657 |
|
|
2019
Q2 | $14.6M | Buy |
577,997
+90,565
| +19% | +$2.29M | ﹤0.01% | 1691 |
|
|
2019
Q1 | $9.5M | Buy |
487,432
+65,583
| +16% | +$1.28M | ﹤0.01% | 1930 |
|
|
2018
Q4 | $5.56M | Buy |
421,849
+48,603
| +13% | +$641K | ﹤0.01% | 2156 |
|
|
2018
Q3 | $6.64M | Buy |
373,246
+13,044
| +4% | +$232K | ﹤0.01% | 2185 |
|
|
2018
Q2 | $7.92M | Buy |
360,202
+210,210
| +140% | +$4.62M | ﹤0.01% | 2053 |
|
|
2018
Q1 | $3.32M | Buy |
149,992
+3,797
| +3% | +$83.9K | ﹤0.01% | 2490 |
|
|
2017
Q4 | $3.17M | Buy |
+146,195
| New | +$3.17M | ﹤0.01% | 2486 |
|